Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osotspa Taisho is a strategic joint venture between the Thai consumer goods giant Osotspa and the Japanese pharmaceutical leader Taisho Pharmaceutical. The company specializes in the manufacturing, marketing, and distribution of over-the-counter (OTC) pharmaceutical products and health supplements within the Thai market. Its most recognizable product is the energy drink Lipovitan-D, which pioneered the category in Thailand. Additionally, the company manages a robust portfolio of healthcare brands, including the analgesic balm Counterpain and the cold remedy Pabron. By combining Taisho's pharmaceutical innovation with Osotspa's extensive local distribution network, Osotspa Taisho has maintained a dominant position in the Southeast Asian consumer health sector for decades.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osotspa Taisho.